JPH02237954A - Production of 4-hydroxy-2-cyclopentenone derivative - Google Patents
Production of 4-hydroxy-2-cyclopentenone derivativeInfo
- Publication number
- JPH02237954A JPH02237954A JP1059333A JP5933389A JPH02237954A JP H02237954 A JPH02237954 A JP H02237954A JP 1059333 A JP1059333 A JP 1059333A JP 5933389 A JP5933389 A JP 5933389A JP H02237954 A JPH02237954 A JP H02237954A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- lithium
- group
- formula
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DHNDDRBMUVFQIZ-UHFFFAOYSA-N 4-hydroxycyclopent-2-en-1-one Chemical class OC1CC(=O)C=C1 DHNDDRBMUVFQIZ-UHFFFAOYSA-N 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 12
- 229910052744 lithium Inorganic materials 0.000 claims abstract description 11
- AINRQBNLOBQURT-UHFFFAOYSA-N 3-hydroxypent-4-enoic acid Chemical class C=CC(O)CC(O)=O AINRQBNLOBQURT-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 4
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 4
- -1 alkyl lithium Chemical compound 0.000 claims description 15
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 27
- 150000004808 allyl alcohols Chemical class 0.000 abstract description 8
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 abstract description 8
- 239000007858 starting material Substances 0.000 abstract description 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 21
- 238000000034 method Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 230000003287 optical effect Effects 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- KYPJODYLZIOMTO-GQCTYLIASA-N (e)-3-trimethylsilylprop-2-enal Chemical compound C[Si](C)(C)\C=C\C=O KYPJODYLZIOMTO-GQCTYLIASA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- WOPKYMRPOKFYNI-UHFFFAOYSA-N 2-hydroxycyclopent-2-en-1-one Chemical compound OC1=CCCC1=O WOPKYMRPOKFYNI-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 229910003002 lithium salt Inorganic materials 0.000 description 2
- 159000000002 lithium salts Chemical class 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- YQYGPGKTNQNXMH-UHFFFAOYSA-N 4-nitroacetophenone Chemical group CC(=O)C1=CC=C([N+]([O-])=O)C=C1 YQYGPGKTNQNXMH-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 101000841267 Homo sapiens Long chain 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 102100029107 Long chain 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- IGRLIBJHDBWKNA-UHFFFAOYSA-N cyclopent-4-ene-1,3-diol Chemical compound OC1CC(O)C=C1 IGRLIBJHDBWKNA-UHFFFAOYSA-N 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical class OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000005657 iodolactonization reaction Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- IHLVCKWPAMTVTG-UHFFFAOYSA-N lithium;carbanide Chemical compound [Li+].[CH3-] IHLVCKWPAMTVTG-UHFFFAOYSA-N 0.000 description 1
- QBZXOWQOWPHHRA-UHFFFAOYSA-N lithium;ethane Chemical compound [Li+].[CH2-]C QBZXOWQOWPHHRA-UHFFFAOYSA-N 0.000 description 1
- QHSTXVAUZZDMOS-UHFFFAOYSA-N lithium;ethene Chemical compound [Li+].[CH-]=C QHSTXVAUZZDMOS-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000004492 methyl ester group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 125000003638 stannyl group Chemical group [H][Sn]([H])([H])* 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- LLZRNZOLAXHGLL-UHFFFAOYSA-J titanic acid Chemical compound O[Ti](O)(O)O LLZRNZOLAXHGLL-UHFFFAOYSA-J 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- CPRPKIMXLHBUGA-UHFFFAOYSA-N triethyltin Chemical group CC[Sn](CC)CC CPRPKIMXLHBUGA-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- LYRCQNDYYRPFMF-UHFFFAOYSA-N trimethyltin Chemical group C[Sn](C)C LYRCQNDYYRPFMF-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利 野
本発明は、医薬品、農薬品の中間体,特にプロスタグラ
ンジン系医薬品の合成中間体として有用な下記一般式(
m)又は(IV)
唾〕〔■〕
(但し、式中Rは水素原子又は水酸基の保護基である.
)
で示される光学活性な4−ヒドロキシ−2−シクロペン
テノン誘導体の製造法に関する.l米立ユ亙
従来、光学活性な4−ヒドロキシ−2−シクロペンテノ
ン誘導体の合成方法としては,下記■〜■なとの方法が
知られている.
Φ 光学活性な3,5−ジヒドロキシーシクロペンテン
の片末端の水酸基を選択的に酸化する方法(田中,黒住
ら, Tetrahedron Lett., 3 2
.1713(1976)等).
■ フラン誘導体の転位反応でラセミ体の4−ヒドロキ
シー2−シクロペンテノンを得た後,これをアシル化し
、酵素等で不斉水解する方法(特開昭5.7−6223
6号,同63−109797号公報等)。[Detailed Description of the Invention] Industrial Benefits The present invention provides compounds of the following general formula (
m) or (IV) Saliva] [■] (However, in the formula, R is a hydrogen atom or a hydroxyl group-protecting group.
) relates to a method for producing an optically active 4-hydroxy-2-cyclopentenone derivative. As methods for synthesizing optically active 4-hydroxy-2-cyclopentenone derivatives, the following methods 1 to 2 have been known. Φ Method of selectively oxidizing the hydroxyl group at one end of optically active 3,5-dihydroxy-cyclopentene (Tanaka, Kurosumi et al., Tetrahedron Lett., 32
.. 1713 (1976) etc.). ■ A method in which racemic 4-hydroxy-2-cyclopentenone is obtained by a rearrangement reaction of a furan derivative, and then acylated and asymmetrically hydrolyzed with enzymes (Japanese Patent Laid-Open No. 57-6223
No. 6, Publication No. 63-109797, etc.).
■ 4−ヒドロキシ−2−シクロペンテノンのラセミ体
を不斉ロジウム触媒で選択的に異性化させ,速度論的に
光学分割する方法(野依ら、Tetrahedronし
ett., 28, 4719 (1987))
。■ A method of selectively isomerizing the racemic form of 4-hydroxy-2-cyclopentenone with an asymmetric rhodium catalyst and kinetically resolving it (Noyori et al., Tetrahedron ett., 28, 4719 (1987))
.
■ 4−ヒドロキシ−2−シクロペンテノンのラセミ体
を光学分割剤と結合させてジアステレオマー、分離をし
た後、光学分割剤を脱離して光学活性体を得る方法(特
開昭57−159777号公報等)。■ A method of combining the racemic form of 4-hydroxy-2-cyclopentenone with an optical resolving agent to separate diastereomers, and then removing the optical resolving agent to obtain an optically active form (JP-A-57-159777 Publications, etc.).
■ 4−ヒドロキシ−2−シクロペンテノンのラセミ体
を光学分割液クロカラムクロマト分離する方法(特開昭
61−267536号公報等)。(2) A method for separating the racemic form of 4-hydroxy-2-cyclopentenone by optical resolution liquid chromatography (JP-A-61-267536, etc.).
が しよ゛と る
しかしながら,上記■の方法は得られる4−ヒドロキシ
−2−シクロペンテノンの光学純度が十分に満足できる
ものではない.また、上記■〜■の方法は光学分割とい
う操作を最後に行なう必要があるため、折角得られた4
−ヒドロキシ−2−シクロペンテノンのうちの半量以上
は無駄になってしまうという欠点があり、しかも、■の
方法では酵素を使用するため水系の反応になるが、4−
ヒドロキシ−2−シクロペンテノンは極端に水溶性でか
つ不安定な化合物であるので、反応液中からの取り出し
操作が容易でなく、■及び■の方法は、使用する触媒や
光学分割のために用いる担体が高価で経済的に不利であ
り、更に,■の方法は光学分割だけの操作に3工程も必
要である上、等モルの光学分割剤を要するので,工程が
面倒かつ不経済であるという問題点もある。However, the optical purity of the 4-hydroxy-2-cyclopentenone obtained by method (2) above is not fully satisfactory. In addition, in the methods ① to ② above, it is necessary to perform the optical splitting operation at the end.
-The disadvantage is that more than half of the hydroxy-2-cyclopentenone is wasted.Moreover, method (2) uses an enzyme and is therefore a water-based reaction;
Hydroxy-2-cyclopentenone is an extremely water-soluble and unstable compound, so it is difficult to remove it from the reaction solution, and methods The carrier used is expensive and economically disadvantageous. Furthermore, method (2) requires three steps just for optical resolution and requires an equimolar amount of optical resolving agent, making the process cumbersome and uneconomical. There is also a problem.
本発明は、このように従来の方法では短工程で工業的に
有利に製造することが困難であった光学活性な4−ヒド
ロキシ−2−シクロペンテノン誘導体の新規な製造法を
提供することを目的とする。The present invention thus aims to provide a novel method for producing optically active 4-hydroxy-2-cyclopentenone derivatives, which has been difficult to produce industrially advantageously in a short process using conventional methods. purpose.
めの び
本発明者は、上記事情に鑑み、光学活性な4−ヒドロキ
シ−2−シクロペンテノン誘導体を短工程で工業的に有
利に合成するため、種々の光学活性アリルアルコール誘
導体を用いて鋭意検討を重ねた結果、本発明者が先に出
願した特願昭62−189234号,更には特願昭62
−170299号、同62−238169号に提案した
方法で容易に合成できる光学的に純粋な光学活性アリル
アルコール誘導体である下記一般式CI)又は一般式(
n)
〔但し、式中Xは塩素原子、臭素原子、ヨウ素原子又は
トリ(低級アルキル)スズ基であり、R’は水酸基の保
護基である。〕
で示される光学活性な3−ヒドロキシ−4−ペンテン酸
誘導体に低級アルキルリチウムを作用させ、続いてt−
ブチルリチウムを作用させることにより、下記一般式〔
■〕
又は一般式(II)
ξ
OR
又は一般式(IV)
n
(但し、Rは水素原子又は水酸基の保fl.iitを示
す.)
で示される光学活性な4−ヒドロキシ−2−シクロペン
テノン誘導体を短工程でかつ光学分割操作を行なうこと
なく、工業的に有利に合成できることを見い出し、本発
明をなすに至った.以下、本発明につき更に詳述する.
本発明の製造法は、上述したように下記一般式〔I〕
で示される光学活性な3−ヒドロキシ−4−ペンテン酸
誘導体に低級アルキルリチウムを作用させ、続いてt−
ブチルリチウムを作用させて、下記一般式〔■〕
n
又は一般式(IV)
で示される光学活性な4−ヒドロキシ−2−シクロペン
テノン誘導体を得るものである.ここで,本発明方法で
出発原料として使用する上記(1)式及び(II)式の
化合物において、式中のXは塩素原子、臭素原子,ヨウ
素原子又はトリ(低級アルキル)スズ基である。なお、
トリ(低級アルキル)スズ基としては,炭素数1〜5の
低級アルキル基を有するもの、例えばトリメチルスズ基
,トリエチルスズ基などが挙げられる。In view of the above circumstances, the inventors of the present invention have made extensive efforts using various optically active allyl alcohol derivatives in order to industrially advantageously synthesize optically active 4-hydroxy-2-cyclopentenone derivatives in short steps. As a result of repeated consideration, we found that the present inventor had previously filed Japanese Patent Application No. 189234/1982, and also Japanese Patent Application No. 1983
-170299, the following general formula (CI) or the general formula (
n) [However, in the formula, X is a chlorine atom, a bromine atom, an iodine atom, or a tri(lower alkyl)tin group, and R' is a hydroxyl group-protecting group. ] The optically active 3-hydroxy-4-pentenoic acid derivative represented by is treated with lower alkyl lithium, and then t-
By acting with butyllithium, the following general formula [
[■] Or an optically active 4-hydroxy-2-cyclopentenone represented by the general formula (II) ξ OR or the general formula (IV) n (wherein, R represents a hydrogen atom or a hydroxyl group retention fl.iit) The present inventors have discovered that derivatives can be industrially advantageously synthesized in a short process and without optical resolution operations, leading to the present invention. The present invention will be explained in more detail below. As mentioned above, in the production method of the present invention, an optically active 3-hydroxy-4-pentenoic acid derivative represented by the following general formula [I] is reacted with a lower alkyl lithium, and then t-
By reacting with butyllithium, an optically active 4-hydroxy-2-cyclopentenone derivative represented by the following general formula [■] n or general formula (IV) is obtained. Here, in the compounds of formula (1) and formula (II) used as starting materials in the method of the present invention, X in the formula is a chlorine atom, a bromine atom, an iodine atom, or a tri(lower alkyl)tin group. In addition,
Examples of the tri(lower alkyl)tin group include those having a lower alkyl group having 1 to 5 carbon atoms, such as a trimethyltin group and a triethyltin group.
また、上記[I)及び[II)式中のR′は水酸基の保
護基、[III)及びCTVE式中のRは水素原子又は
水酸基の保護基である。ここで、水酸基の保護基として
具体的には、トリアルキルシリル基(例えばトリメチル
シリル基,t−プチルジメチルシリル基,フェニルジメ
チルシリル基)、アルコキシアルキル基(例えばメトキ
シメチル基,エトキシエチル基,テトラヒドロピラニル
基),アラルキルオキシアルキル基(例えばペンジルオ
キシメチル基)、トリチル基,更にはアシル基(例えば
アセチル基,P−ニトロベンゾイル基)等が挙げられる
.
本発明では,上記(13又は〔■〕式の3−ヒドロキシ
−4−ペンテン酸誘導体にまず第1段階反応として低級
アルキルリチウムを作用させるもので、この第1段階反
応で(1)又は(II)式の3−ヒドロキシ−4−ペン
テン酸誘導体の末端のカルボニル基がリチウム塩に変換
する。Further, R' in formulas [I) and [II] above is a hydroxyl group-protecting group, and R in [III) and CTVE formula is a hydrogen atom or a hydroxyl group-protecting group. Here, specific examples of hydroxyl protecting groups include trialkylsilyl groups (e.g. trimethylsilyl group, t-butyldimethylsilyl group, phenyldimethylsilyl group), alkoxyalkyl groups (e.g. methoxymethyl group, ethoxyethyl group, tetrahydropyranyl group), Examples include aralkyloxyalkyl groups (eg, penzyloxymethyl group), trityl groups, and acyl groups (eg, acetyl group, P-nitrobenzoyl group). In the present invention, the 3-hydroxy-4-pentenoic acid derivative of formula (13 or ) The terminal carbonyl group of the 3-hydroxy-4-pentenoic acid derivative of the formula is converted into a lithium salt.
この場合、低級アルキルリチウムとしては、炭素数が1
〜5の低級アルキルリチウム、例えばメチルリチウム,
エチルリチウム,n−ブチルリチウム,t−ブチルリチ
ウム等が好適に用いられるもので、低級アルキルリチウ
ムとして後述する第2段階反応と共通のt−ブチルリチ
ウムを用いることが最適である.
また、低級アルキルリチウムは、無水条件下で(1)又
は[I[]式の化合物に作用させることが好ましく、反
応時には予め系内の水分を極カ減らしておくことが望ま
しいが、系内に混入してくる水分で低級アルキルリチウ
ムの一部が消費されることが十分考えられる。それ故,
低級アルキルリチウムの使用量は、[1)又は(11)
式の化合物1モルに対して1〜1,5モル当量が好適で
ある。低級アルキルリチウムの使用量が1モル当量より
少ないと反応が十分に進まない場合があり、1.5モル
当量より多いと過剰分が無駄となり、経済的メリットが
低下する。In this case, the lower alkyl lithium has a carbon number of 1
~5 lower alkyllithium, such as methyllithium,
Ethyllithium, n-butyllithium, t-butyllithium, etc. are preferably used, and it is optimal to use t-butyllithium, which is common to the second stage reaction described later, as the lower alkyllithium. In addition, it is preferable that the lower alkyl lithium is allowed to act on the compound of formula (1) or [I[] under anhydrous conditions, and it is desirable to reduce the amount of moisture in the system in advance in advance, but It is quite conceivable that some of the lower alkyl lithium is consumed by the mixed moisture. Therefore,
The amount of lower alkyl lithium used is [1) or (11)
1 to 1.5 molar equivalents per mole of the compound of formula are suitable. If the amount of lower alkyl lithium used is less than 1 molar equivalent, the reaction may not proceed sufficiently, and if it is more than 1.5 molar equivalent, the excess amount will be wasted and the economic merit will decrease.
次いで、本発明では、このように〔■〕又は(II)式
の3−ヒドロキシ−4−ペンテン酸誘導体に低級アルキ
ルリチウムを作用させたものに引き続いて第2段階とし
てt−ブチルリチウムを作用させる。この第2段階反応
は、(1)又は[II)式の3−ヒドロキシ−4−ペン
テン酸誘導体の末端のカルボニル基のα位のア二オン(
第1段階反応によるリチウム塩形成を含めるとジアニオ
ン)形成及びビニルリチウム形成処理である。Next, in the present invention, following the reaction of lower alkyllithium with the 3-hydroxy-4-pentenoic acid derivative of formula [■] or (II), as a second step, t-butyllithium is applied. . This second step reaction consists of an anion (
Including the formation of lithium salt by the first stage reaction, this is a process for forming dianion) and vinyllithium.
ここで、t−ブチルリチウムの使用量は別に制限されな
いが、CI)又は[II)式の化合物1モルに対して1
.5〜4モル当量、特に2〜3.5モル当量が好ましく
、使用量が1.5モル当量より少ないと反応が十分に進
まない場合があり、4モル当量より多いと過剰分が無駄
となり、経済的メリットが低下する。Here, the amount of t-butyllithium used is not particularly limited, but 1 mole of the compound of formula CI) or [II)
.. 5 to 4 molar equivalents, particularly 2 to 3.5 molar equivalents are preferred; if the amount used is less than 1.5 molar equivalents, the reaction may not proceed sufficiently; if it is more than 4 molar equivalents, the excess amount will be wasted; Economic benefits are reduced.
更に、上記第1,2段階反応は有機溶媒中で行なうこと
が望ましく、有機溶媒として具体的にはジエチルエーテ
ル等のエーテル類や、これらエーテル類と本発明反応に
直接関与しない非反応性の有機溶媒(例えばヘキサン,
ペンタン等の炭化水素類など)との混合溶媒などが好適
に用いられる.なお、有機溶媒は十分乾燥されたものを
使用することが好ましい。Furthermore, it is preferable to carry out the first and second step reactions in an organic solvent, and examples of the organic solvent include ethers such as diethyl ether, and non-reactive organic solvents that do not directly participate in the reaction of the present invention with these ethers. Solvent (e.g. hexane,
Mixed solvents with hydrocarbons (such as pentane, etc.) are preferably used. Note that it is preferable to use a sufficiently dried organic solvent.
また、反応温度は第1,2段階反応共に低温にすること
が望ましく、第1段階反応は−30〜−90゜C、特に
−60〜−90゜C、第2段階反応は−60〜−90℃
の範囲が好適であり,操作の簡便さの点からは第1,2
段階を−70〜−80℃で通して反応を行なうことが好
ましい。In addition, it is desirable that the reaction temperature is low for both the first and second stage reactions; the first stage reaction is -30 to -90°C, especially -60 to -90°C, and the second stage reaction is -60 to -90°C. 90℃
The range of 1 and 2 is preferable from the viewpoint of ease of operation.
Preferably, the reaction is carried out through the steps at -70 to -80°C.
このようにして得られる4−ヒドロキシ−2−シクロペ
ンテノン誘導体はRが水酸基の保護基(R′)であるが
、これは必要に応じて常法により脱保護でき、Rが水素
原子である光学活性な4一ヒドロキシ−2−シクロペン
テノンに導くことができる。In the 4-hydroxy-2-cyclopentenone derivative thus obtained, R is a hydroxyl protecting group (R'), but this can be removed by a conventional method if necessary, and R is a hydrogen atom. This can lead to optically active 4-hydroxy-2-cyclopentenone.
なお、本発明に出発原料として使用する一般式(13,
(n)式の光学活性な3−ヒドロキシー4一ペンテン酸
誘導体は、本発明者が先に出願した特願昭62−189
234号、更には特願昭62−170299号,同62
−238169号に提案した方法で光学的に純粋に合成
し得る光学活性フリルアルコール誘導体から容易に製造
することができる。In addition, the general formula (13,
The optically active 3-hydroxy-4-pentenoic acid derivative of formula (n) is disclosed in Japanese Patent Application No. 62-189 previously filed by the present inventor.
No. 234, as well as Japanese Patent Application No. 170299/1983, No. 62
It can be easily produced from an optically active furyl alcohol derivative that can be synthesized in an optically pure manner by the method proposed in Japanese Patent No. 238169.
即ち、常法、例えば■エノンのケトン還元、■ビニル金
属試薬とアルデヒドの反応、■アセチレンアルコールの
トランス水素化等で合成できる下記一般式(V)
OH
〔式中、R1は炭素数1〜10の置換もしくは未ここで
、R”, R”, R”は炭素数1〜10の置換もしく
は未置換のアルキル基又は置換もしくは未置換のフェニ
ル基を示し、互いに同一であっても異なっていてもよい
。)
で表わされ、下記一般式(VI)及び〔■〕0H
に示される光学活性アリルアルコールがラセミ体又は混
合物として含有されるγ位にシリル基又はスタニル基を
有するトランス型のアリルアルコールをチタンテトラア
ルコキサイド及び光学活性酒石酸ジエステルの存在下に
ハイドロパーオキサイドで酸化して、この光学活性酒石
酸ジエステルの光学活性に応じて上記光学活性アリルア
ルコール誘導体(VI)又は゛〔■〕を優先的に反応さ
せることにより、上記光学活性アリルアルコール誘導体
〔■〕又は(VI)を光学的に純粋に合成できる.上記
CI),(n)の3−ヒドロキシー4−ペンテン酸誘導
体は、前記方法で得られる光学的に純粋なアリルアルコ
ールを使用し、例えば下記反応式に示すように下記式(
i)の光学活性アリルアルコールのエステル部分を加水
分解し、続いてヨウ素を用いてヨードラクトン化反応後
,得られるラクトン体〔且〕を’Eu4NFで処理する
ととドロキシカルボン酸〔■〕が得られ、更にこれをt
B u M e, Si(Jを用いてジシリル体とした
後、K2C○,を作用させると選択的な脱保護が起こっ
て〔I′〕式の3−ヒドロキシ−4−ペンテン酸誘導体
を収率良く得るといった方法で容易に製造することがで
きる。That is, the following general formula (V) OH [wherein R1 is a carbon number of 1 to 10 Substituted or unsubstituted Here, R", R", and R" represent a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or unsubstituted phenyl group, and may be the same or different from each other. trans-type allyl alcohol having a silyl group or stannyl group at the γ-position and containing optically active allyl alcohol represented by the following general formula (VI) and [■] 0H as a racemate or a mixture. is oxidized with hydroperoxide in the presence of titanium tetraalkoxide and optically active tartaric acid diester, and the optically active allyl alcohol derivative (VI) or ゛[■] is given priority depending on the optical activity of the optically active tartaric acid diester. The above-mentioned optically active allyl alcohol derivative [■] or (VI) can be synthesized in an optically pure manner by reacting the above-mentioned optically active allyl alcohol derivative [■] or (VI). Using the obtained optically pure allyl alcohol, for example, as shown in the reaction formula below, the following formula (
Hydrolyzing the ester moiety of the optically active allyl alcohol in i), followed by an iodolactonization reaction using iodine, and treating the resulting lactone [] with 'Eu4NF yields droxycarboxylic acid [■]. and then add this to t
B u M e, Si (J is used to form a disilyl compound, and then K2C○, is applied to selective deprotection to yield a 3-hydroxy-4-pentenoic acid derivative of the formula [I']. It can be easily manufactured by a method that can be easily obtained.
(i)
ILZυ九呆
以上説明したように、本発明の製造法によれば、医薬品
や農薬品の中間体、特にプロスタグランジン系医薬品の
合成中間体として有用な下記一般式〔■〕又は(rV)
で表わされる光学活性な4−ヒドロキシー2−シクロベ
ンテノン誘導体を短工程で、しかも光学分割の工程を要
さず工業的に有利に製造することができる。(i) ILZυ9 As explained above, according to the production method of the present invention, the following general formula [■] or ( rV)
The optically active 4-hydroxy-2-cyclobentenone derivative represented by can be industrially advantageously produced in a short process and without the need for an optical resolution step.
以下、参考例と実施例を示して本発明を具体的に説明す
るが、本発明は下記実施例に制限されるものではない.
なお、以下の例においてMeはメチル基, ”Buはt
−ブチル基,nBuはn−ブチル基,iPrはイソプロ
ビル基,Et20はジエチルエーテル、THFはテトラ
ヒド口フラン,DMFは. N, N−ジメチルホルム
アミドを示す。The present invention will be specifically explained below with reference to Reference Examples and Examples, but the present invention is not limited to the following Examples. In addition, in the following examples, Me is a methyl group, "Bu is a t
-butyl group, nBu is n-butyl group, iPr is isoprobyl group, Et20 is diethyl ether, THF is tetrahydrofuran, DMF is . Indicates N,N-dimethylformamide.
〔参考例1〕
〔工′〕
((RS)−3)
ジイソプ口ピルアミン(30−Omle 214mmo
f!)のTHF溶液(200mil)をO℃に冷却し.
”BuLi(1 1 1 mQ, 1 7 0mmo
l!,ヘキサン中1.53M)を滴下し、0℃で20分
間撹拌した.この溶液を一70℃に冷却し,酢酸ブチル
(1)(19.8uQ,1 5 0+++moR)をゆ
っくり滴下して20分間撹拌後、(E)−3−トリメチ
ルシリルー2−プロペナール(2)(16.64g,1
28m++on)を−70℃でゆっくり滴下し、その温
度のままで20分間撹拌した。次に,反応液を氷冷した
NH4G2飽和水溶液(700mll)に注ぎ、有機層
を分離後、水層をヘキサンージエチルエーテル(5:1
)で数回抽出した.抽出液を飽和食塩水で洗い、乾燥(
MgSO4)後,減圧下で溶媒を留去し、得られる油状
物質を蒸留(110〜124℃/0.4IIv+Hg)
すると,化合物((RS)−3)(収量:24.19g
,収率:77%)が得られた.
〈化合物((RS)−3)の特性値〉
”HNMR (CCL)δ:
0.14 (S, 9H), 1.16−1.93 (
my 4}1), 2.43(d, J==6.0Hz
, 2H), 3.25 (brs, IH), 4.
05Dr J=6.0Hz, 2H), 4.26−4
.57 (a+, IH),5.82 (d, J=1
9.0Hz, 18), 6.02 (dd, J=1
9.0,3.0Hz, LH)
I R (neat) : 3450, 3000,
1720, 1245,835 (an−’)
b p : 11.0−124℃/0.4mmHg〔参
考例2〕
((RS)−3)
((R)−3)
オルトチタン酸イソプロポキシド
(Ti(OiPr)4,
1 0.3 7mQ, 3 4.8 6mmofi)の
ジクロ口メタン溶液(140d)に−20℃でL−(+
)一酒石酸ジイソプロビル(L−(+)一D I PT
, 8.8 0ml,4 1 . 8 :3+mofl
)を滴下して1o分間撹拌後、参考例1で得られた化合
物[(RS)−3)(5.67g,2 3 . 2 4
mmoJi)のジクロロメタン溶液(15mQ)ヲ滴下
し、−20’Cで20分間撹拌した6次に,無水t−プ
チルヒド口ベルオキシド(TBHP)のジクロロメタン
溶液(8.05mll,34.86mmofi,塩化メ
チレン中4.33M)をゆっくり滴下した後、−20’
Cで18時間撹拌した。更に,ジメチルスルフィド(4
mQ, 5 4 . 5mmoff)を加えて−20
℃で1時間撹拌した後、この反応溶液を10%酒石酸溶
液(22ndl)とエチルエーテル(200ntQ)と
の混合液にあけ、室温で1o分間撹拌ののち、セライト
(Log)及びフッ化ナトリウム(2 0 g)を加え
,室温で30分間撹拌した。抽出物をセラント炉過し、
残渣をエチルエーテルで数回洗浄した.炉液を濃縮後、
得られる油状物質をシリカゲルクロマトにより精製する
と、化合物((R)−3)(収量:2.495g,収率
:44%)が淡黄色油状物として得られた.〈化合物(
(R)−3)の特性値〉
((!) ”,’ +6. 1 3゜(c 1.63.
CH(j!z)対応するMTPAエステル(α−メト
キシーα−トリフロロメチルフエニルWPaの光学活性
体)に変換し、”HNMR分析により〉99%eeであ
ることを確認した.
’HNMR,IRデータは、参考例1のラセミ体(化合
物((RS)−3))のデータと一致した.〔参考例3
〕
((R)−3)
〔4〕
参考例2で得られた化合物((R) − 3)(9 7
6rrz, 4. 0mmof)のTHF (5mQ
)−Et,O (5mu) − MeO H ( 2
. 5 d)溶液に3N水酸化ナトリウム水溶液(1.
5d)を加え、室温で一晩撹拌した。これに重炭酸ナト
リウム水溶液(10mQ)を加え、反応混合液を0℃に
冷却した後、工2(1.52g,5.99mmoffi
)を加えてO℃で1時間撹拌した。反応液をチオ硫酸ナ
トリウム飽和水溶液(50d)にあけ、混合物をエーテ
ルー酢酸エチル(200aQX3)で抽出し、抽出液を
乾燥(M g S 04)後、減圧下で溶媒を留去する
と、油状物(1.llg)が得られた。[Reference Example 1] [Tech'] ((RS)-3) Diisopropylamine (30-Omle 214mmo
f! ) was cooled to 0° C. in THF (200 mil).
”BuLi (1 1 1 mQ, 1 70 mmo
l! , 1.53M in hexane) was added dropwise and stirred for 20 minutes at 0°C. This solution was cooled to -70°C, and butyl acetate (1) (19.8 uQ, 1 5 0+++ moR) was slowly added dropwise, and after stirring for 20 minutes, (E)-3-trimethylsilyl-2-propenal (2) (16 .64g, 1
28m++on) was slowly added dropwise at -70°C, and the mixture was stirred at that temperature for 20 minutes. Next, the reaction solution was poured into an ice-cooled NH4G2 saturated aqueous solution (700ml), the organic layer was separated, and the aqueous layer was separated into hexane-diethyl ether (5:1
) was extracted several times. Wash the extract with saturated saline and dry (
After MgSO4), the solvent was distilled off under reduced pressure, and the resulting oil was distilled (110-124℃/0.4IIv+Hg).
Then, compound ((RS)-3) (yield: 24.19g
, yield: 77%) was obtained. <Characteristic values of compound ((RS)-3)>"HNMR (CCL) δ: 0.14 (S, 9H), 1.16-1.93 (
my 4}1), 2.43(d, J==6.0Hz
, 2H), 3.25 (brs, IH), 4.
05Dr J=6.0Hz, 2H), 4.26-4
.. 57 (a+, IH), 5.82 (d, J=1
9.0Hz, 18), 6.02 (dd, J=1
9.0, 3.0Hz, LH) I R (neat): 3450, 3000,
1720, 1245,835 (an-') bp: 11.0-124°C/0.4 mmHg [Reference Example 2] ((RS)-3) ((R)-3) Orthotitanic acid isopropoxide (Ti Add L-(+
) Diisoprobyl monotartrate (L-(+)-DI PT
, 8.80ml, 41. 8:3+mofl
) was added dropwise and stirred for 10 minutes, and then the compound [(RS)-3) obtained in Reference Example 1 (5.67 g, 2 3 . 2 4
A dichloromethane solution (15 mQ) of MmoJi) was added dropwise and stirred for 20 minutes at -20'C. Next, a dichloromethane solution (8.05 ml, 34.86 mmofi, of anhydrous t-butylic hydroxide (TBHP) in methylene chloride was added dropwise and stirred for 20 minutes at -20'C. After slowly dropping 4.33M), -20'
Stirred at C for 18 hours. Furthermore, dimethyl sulfide (4
mQ, 5 4. 5mmoff) and -20
After stirring at ℃ for 1 hour, this reaction solution was poured into a mixture of 10% tartaric acid solution (22 ndl) and ethyl ether (200 ntQ), and after stirring at room temperature for 10 minutes, celite (Log) and sodium fluoride (2 ndl) were poured into the mixture. 0 g) and stirred at room temperature for 30 minutes. The extract was passed through a Celant furnace;
The residue was washed several times with ethyl ether. After concentrating the furnace liquid,
The resulting oily substance was purified by silica gel chromatography to obtain compound ((R)-3) (yield: 2.495g, yield: 44%) as a pale yellow oily substance. <Compound(
Characteristic value of (R)-3)〉 ((!) ”,' +6. 1 3゜(c 1.63.
CH(j!z) was converted to the corresponding MTPA ester (optically active form of α-methoxy α-trifluoromethylphenyl WPa) and confirmed to be >99% ee by HNMR analysis. HNMR, IR The data agreed with the data of the racemate (compound ((RS)-3)) of Reference Example 1. [Reference Example 3
] ((R)-3) [4] Compound obtained in Reference Example 2 ((R)-3) (9 7
6rrz, 4. 0mmof) of THF (5mQ
)-Et,O (5mu)-MeOH (2
.. 5 d) Add 3N aqueous sodium hydroxide solution (1.
5d) was added and stirred at room temperature overnight. After adding an aqueous sodium bicarbonate solution (10 mQ) to this and cooling the reaction mixture to 0°C, Step 2 (1.52 g, 5.99 mmoffi) was added.
) and stirred at 0° C. for 1 hour. The reaction solution was poured into a saturated aqueous solution of sodium thiosulfate (50d), the mixture was extracted with ether-ethyl acetate (200aQX3), the extract was dried (M g S 04), and the solvent was distilled off under reduced pressure to give an oily substance ( 1.llg) was obtained.
次に、この油状物をTHF (10ntQ)に溶解し,
0℃に冷却後,テトラブチルアンモニウムクロライドの
THF溶液(6. 0Ifi!Q, 4. 0 2mm
all,THF中0.67M)を滴下した。0℃で30
分間撹拌してNH4CQ飽和水溶液(10d)にあけ、
水層がpH4になるまで希塩酸を少しずつ加え、混合液
をクロロホルム(20ndlX4)で抽出した。この抽
出液を乾燥(M g S 04)後、減圧下で溶媒を留
去し,得られる残渣をジエチルエーテルに溶解してシリ
カゲルで炉過すると、化合物〔4〕(収量:720■,
収率:85%)が得られた.この化合物〔4〕のメチル
エステル体は”HNMR分析により〉95%2体であり
、化合物〔4〕はこれ以上精製することなしに次の反応
に用いた.
〈化合物〔4〕の特性値〉
″HNMR (CDCら)δ:
258 (d, J=6,OHz, 2H), 4.5
0−4.90 (m, IH),6.17−6.48
(m, 2H), 6.75 (brs, 2H).〔
参考例4〕
〔4〕
〔工′〕
参考例3で得られた化合物(4)(7 2 0■,3.
0mmojl) . tBuMa.SiCji
(1 . 3 6 g , 9mmoj!)
、イミダゾール(8 1 6ffil 1 2++
u++offi)のDMF溶液(5−)を室温で一晩撹
拌した。これにNaCΩ飽和水溶液(20m!)を加え
、混合液をヘキサン(20+1QX3)で抽出した後、
抽出液をNaCR飽和水溶液で洗浄し,乾燥(MgSO
.)L、減圧下で溶媒を留去し、油状物を得た.次に、
得られた油状物をMeOH−THF−H,O (5 :
2 : 2,28mll)に溶解し、炭酸カリウム(
415.,3mmon)を加え、室温で10分間撹拌し
た。反応液をpHが5の緩衝溶液(30mQ)にあけ、
CHC Q.で数回抽出した。この抽出液を乾燥(Mg
S○,)し、減圧下で溶媒を留去して得られた粗精製物
をシリカゲル力ラムで精製したところ、化合物〔工′〕
(収量:820■,収率:80%)が油状物として得ら
れた。Next, dissolve this oil in THF (10ntQ),
After cooling to 0°C, a THF solution of tetrabutylammonium chloride (6.0Ifi!Q, 4.02mm
all, 0.67 M in THF) was added dropwise. 30 at 0℃
Stir for a minute and pour into NH4CQ saturated aqueous solution (10d).
Dilute hydrochloric acid was added little by little until the pH of the aqueous layer reached 4, and the mixture was extracted with chloroform (20 ndl x 4). After drying this extract (M g S 04), the solvent was distilled off under reduced pressure, and the resulting residue was dissolved in diethyl ether and filtered through silica gel, yielding compound [4] (yield: 720 cm,
Yield: 85%) was obtained. The methyl ester form of this compound [4] was found to be 95% 2-form by HNMR analysis, and compound [4] was used in the next reaction without further purification. <Characteristic values of compound [4]> ″HNMR (CDC et al.) δ: 258 (d, J=6, OHz, 2H), 4.5
0-4.90 (m, IH), 6.17-6.48
(m, 2H), 6.75 (brs, 2H). [
Reference Example 4] [4] [Work'] Compound (4) obtained in Reference Example 3 (720■, 3.
0 mmojl). tBuMa. SiCji
(1.36 g, 9 mmoj!)
, imidazole (8 1 6ffil 1 2++
A solution of u++offi) in DMF (5-) was stirred at room temperature overnight. After adding NaCΩ saturated aqueous solution (20m!) to this and extracting the mixture with hexane (20+1QX3),
The extract was washed with a saturated aqueous solution of NaCR and dried (MgSO
.. )L, the solvent was distilled off under reduced pressure to obtain an oily substance. next,
The obtained oil was dissolved in MeOH-THF-H,O (5:
2: 2.28 ml) and potassium carbonate (
415. , 3 mmon) and stirred at room temperature for 10 minutes. Pour the reaction solution into a buffer solution (30 mQ) with a pH of 5,
CHC Q. Extracted several times. This extract was dried (Mg
When the crude product obtained by distilling off the solvent under reduced pressure was purified using a silica gel column, the compound [Work']
(Yield: 820 cm, yield: 80%) was obtained as an oil.
〈化合物〔工′〕の特性値〉
’HNMR (CDCL)δ:
0.07&0.11 (2s, 6}1), 0.86
(st 9H), 2.55(d, J=4.8Hz
, 2H), 4.70−4.96 (01, IH)
,6.16−6.38 (m, 2H).i3CNMR
(CDCれ)δ:
176.6, 142.9, 81.1, 72.7,
41.7, 25.7.1?.9,−4.3,−4.
9.
I R (neat) : 2930, 1705,
1250, 1090,830 (am−”).
〔実施例〕
参考例4で得られた化合物(I’)(650mg,1
.8 2+++mofi)のエーテル溶液(20mll
)を−72℃に冷却し、Me L i (0.8 8
aQ, 1.8 2+mmon,E t,O中2.08
M)を滴下シ、−78℃”t’30分間撹拌した.−7
8℃のままでtB u L i(2.14mQ, 3.
64rrrrmon,ペンタン中1.70M)を滴下し
、更に20分間撹拌を続けた.次に、反応液を氷冷した
NH4Cll飽和水溶液(40all)とジエチルエー
テル(20all)の混合液に注ぎ込み,混合液をジエ
チルエーテル(20mRX3)で抽出した。この抽出液
を乾燥し、減圧下で溶媒を留去して残渣をシリカゲルク
ロマトにより精製すると、化合物(II’) (収量:
288■,収率:75%)が白色結晶として得られた。<Characteristic values of compound [tech']>'HNMR (CDCL) δ: 0.07 & 0.11 (2s, 6}1), 0.86
(st 9H), 2.55 (d, J=4.8Hz
, 2H), 4.70-4.96 (01, IH)
, 6.16-6.38 (m, 2H). i3CNMR
(CDC) δ: 176.6, 142.9, 81.1, 72.7,
41.7, 25.7.1? .. 9, -4.3, -4.
9. I R (neat): 2930, 1705,
1250, 1090,830 (am-”). [Example] Compound (I') obtained in Reference Example 4 (650 mg, 1
.. 8 2+++mofi) in ether solution (20ml
) was cooled to -72°C and Me Li (0.8 8
aQ, 1.8 2+mmon, E t, 2.08 in O
M) was added dropwise and stirred for 30 minutes at -78°C.-7
tB u Li (2.14 mQ, 3.
64rrrrmon, 1.70M in pentane) was added dropwise and stirring continued for an additional 20 minutes. Next, the reaction solution was poured into an ice-cooled mixture of a saturated aqueous solution of NH4Cl (40all) and diethyl ether (20all), and the mixture was extracted with diethyl ether (20mRX3). This extract was dried, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel chromatography to yield compound (II') (yield:
288μ, yield: 75%) was obtained as white crystals.
〈化合物〔■′〕の特性値〉
m p : 28.5−29.5℃(ペンタンより再結
晶したもの)*
((E) ”.’ +6 7.1@(c O.82,
MeOH)”1HNMR (CDCfl3) δ:
0.11&0.12 (2S, 6H), 0.89
(S, 9H), 2.22(dd, J=2.3,
18.1Hz, 18), 2.69 (dd,J=6
.0, 18.1Hz, IH), 4.93−5.0
2 (m, IH),6,17 (dd, J=1.2
, 5.7Hz, IH), 7.44 (dd, J
=2.3, 5.7Hz, IH).
13CNMR (CDCQ3) δ:
206.9, 164.2, 134.7, 70.9
, 44.9, 25.6,18.0, −4.9,<Characteristic values of compound [■']> m p: 28.5-29.5°C (recrystallized from pentane)* ((E) ”.' +6 7.1@(c O.82,
MeOH)”1HNMR (CDCfl3) δ: 0.11 & 0.12 (2S, 6H), 0.89
(S, 9H), 2.22(dd, J=2.3,
18.1Hz, 18), 2.69 (dd, J=6
.. 0, 18.1Hz, IH), 4.93-5.0
2 (m, IH), 6, 17 (dd, J=1.2
, 5.7Hz, IH), 7.44 (dd, J
=2.3, 5.7Hz, IH). 13CNMR (CDCQ3) δ: 206.9, 164.2, 134.7, 70.9
, 44.9, 25.6, 18.0, -4.9,
Claims (1)
トリ(低級アルキル)スズ基であり、R’は水酸基の保
護基である。〕 で示される光学活性な3−ヒドロキシ−4−ペンテン酸
誘導体に低級アルキルリチウムを作用させ、続いてt−
ブチルリチウムを作用させることを特徴とする下記一般
式〔III〕 ▲数式、化学式、表等があります▼・・・・〔III〕 又は一般式〔IV〕 ▲数式、化学式、表等があります▼・・・・〔IV〕 (但し、Rは水素原子又は水酸基の保護基である。) で示される光学活性な4−ヒドロキシ−2−シクロペン
テノン誘導体の製造法。[Claims] 1. The following general formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼...[I] Or general formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼... -(II) [However, in the formula, X is a chlorine atom, a bromine atom, an iodine atom, or a tri(lower alkyl)tin group, and R' is a hydroxyl group-protecting group. ] The optically active 3-hydroxy-4-pentenoic acid derivative represented by is treated with lower alkyl lithium, and then t-
The following general formula [III] characterized by the action of butyllithium ▲There are mathematical formulas, chemical formulas, tables, etc.▼...[III] Or general formula [IV] ▲There are mathematical formulas, chemical formulas, tables, etc.▼・...[IV] (However, R is a hydrogen atom or a hydroxyl group-protecting group.) A method for producing an optically active 4-hydroxy-2-cyclopentenone derivative represented by the following.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1059333A JP2737214B2 (en) | 1989-03-10 | 1989-03-10 | Method for producing 4-hydroxy-2-cyclopentenone derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1059333A JP2737214B2 (en) | 1989-03-10 | 1989-03-10 | Method for producing 4-hydroxy-2-cyclopentenone derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02237954A true JPH02237954A (en) | 1990-09-20 |
JP2737214B2 JP2737214B2 (en) | 1998-04-08 |
Family
ID=13110301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1059333A Expired - Fee Related JP2737214B2 (en) | 1989-03-10 | 1989-03-10 | Method for producing 4-hydroxy-2-cyclopentenone derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2737214B2 (en) |
-
1989
- 1989-03-10 JP JP1059333A patent/JP2737214B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2737214B2 (en) | 1998-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA014331B1 (en) | Process for the production of ezetimibe and intermediates used in this process | |
Bures et al. | The 1, 4 O→ C silyl migrations of various 3-[(trialkylsilyl) oxymethyl]-furans and-thiophenes | |
NL8500986A (en) | STEREO-REGULATED ACETOXYAZETIDINONE PROCEDURE. | |
KR890004560B1 (en) | Process for penem intermediates | |
JP2546559B2 (en) | In-situ production of diisopinocampheyl chloroborane | |
JPH02237954A (en) | Production of 4-hydroxy-2-cyclopentenone derivative | |
JPH0561268B2 (en) | ||
JP3724854B2 (en) | Process for producing 1-azabicyclo [1.1.0] butane | |
JP3684339B2 (en) | Method for producing carbapenem compounds | |
JPH1017561A (en) | Allylalcohol compounds and their production | |
JP3541421B2 (en) | Allene-containing α-substituted cyclopentenone derivatives and method for producing the same | |
KR100201564B1 (en) | Azetidinone compound and their preparation method | |
JP2773118B2 (en) | Optically active allyl alcohol derivative | |
JPH03385B2 (en) | ||
JPH05271148A (en) | Production of optically active alpha-hydrocarboxylic acid | |
JP3403761B2 (en) | 3,5-Dihydroxy-1-octen-7-ynes and method for producing the same | |
JPH04288068A (en) | Optically active fluorine-containing compound | |
JPH07233175A (en) | Asymmetric production of metal-substituted cyclopropylmethanol derivative. | |
JPH05246983A (en) | Vitamin d3 derivative and its production | |
JPH0349912B2 (en) | ||
JPH0220616B2 (en) | ||
JPS62195338A (en) | Asymmetric induction of prochiral cyclic ketone having symmetry plane | |
JPH06321831A (en) | Production of 1-substituted 1,4-dihydroxy-2-cyclopentenone derivative | |
JPH0267273A (en) | Intermediate in lactam derivative production | |
JPH0651676B2 (en) | (5E) -Prostaglandin E (2) Manufacturing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090116 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |